Skip to content

The Rise of Private Credit as a Lucrative Asset Class and Attractive Lending Alternative

By Barbara Tague, Financial Research Leader

Private credit has soared in growth over the last decade, establishing itself as a lucrative asset class and attractive lending alternative to the broadly syndicated market.

Leveraging the AlphaSense platform, we surface intelligence and insights from leading analysts and industry experts to examine private credit’s trajectory and increasing institutional adoption.

AlphaCUT is your trusted source for the trends and intelligence making the most waves in today’s market. Download the report today to discover why experts believe private credit is “here to stay.”

About the Author
  • Barbara Tague, Financial Research Leader

    Barb is a Financial Research Leader covering the financial services segment at AlphaSense. Previously, she spent more than a decade at institutional investment managers and at a SaaS startup leading business development, content, and product initiatives.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.